Milton Werner
Founder bei INHIBIKASE THERAPEUTICS, INC.
Vermögen: 2 Mio $ am 31.03.2024
Profil
Milton H.
Werner is the founder of Inhibikase Therapeutics, Inc. which was founded in 2008.
He holds the title of President, Chief Executive Officer & Director at Inhibikase Therapeutics, Inc. starting in 2012.
Dr. Werner is currently a Member at Winship Cancer Institute.
In the past, he worked as Vice President-Research at Celtaxsys, Inc. in 2007 and as Head-Laboratory of Molecular Biophysics at The Rockefeller University from 1996 to 2007.
Dr. Werner completed his undergraduate degree at the University of Southern California in 1985 and obtained his doctorate degree from the University of California, Berkeley in 1991.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
01.04.2024 | 889 230 ( 14,37% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Milton Werner
Unternehmen | Position | Beginn |
---|---|---|
INHIBIKASE THERAPEUTICS, INC. | Founder | 01.09.2008 |
Winship Cancer Institute | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Milton Werner
Unternehmen | Position | Ende |
---|---|---|
Celtaxsys, Inc.
Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Chief Tech/Sci/R&D Officer | 01.08.2007 |
The Rockefeller University | Corporate Officer/Principal | 01.06.2007 |
Ausbildung von Milton Werner
University of Southern California | Undergraduate Degree |
University of California, Berkeley | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
INHIBIKASE THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Celtaxsys, Inc.
Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Health Technology |
Winship Cancer Institute |